Brendan Hannah
Finanzdirektor/CFO bei QUINCE THERAPEUTICS, INC.
Vermögen: 207 602 $ am 30.04.2024
Aktive Positionen von Brendan Hannah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| QUINCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 16.03.2023 | - |
| Geschäftsführer | 24.10.2023 | - | |
| Finanzdirektor/CFO | 16.03.2023 | - | |
| Corporate Officer/Principal | 01.05.2022 | 16.03.2023 | |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Geschäftsführer | - | - |
Karriereverlauf von Brendan Hannah
Ehemalige bekannte Positionen von Brendan Hannah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | - | 01.12.2016 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Ausbildung von Brendan Hannah
| University of California | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Comptroller/Controller/Auditor | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
- Börse
- Insiders
- Brendan Hannah
- Erfahrung
